Hardik Kamlesh Shah

Hardik Kamlesh Shah

Active Director Designated Partner DIN 02303502
DIN 02303502 First appointment Nov 2011 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since Nov 2011
Shareholding value •••• Premium profile

About Hardik Kamlesh Shah

Data last updated:

Hardik Kamlesh Shah has 14 years in corporate governance. Holds Designated Partner and Whole-Time Director roles. Currently with 5 companies, including Olive Therapeutics Llp and Vedantaa Institutes Of Academic Excellence Private Limited. Formerly with 3 companies, such as Pharmanova Specialties Private Limited and Olive Therapeutics Private Limited. Engaged in General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹183 Cr; the largest is Vedantaa Institutes Of Academic Excellence Private Limited at ₹183 Cr (FY 2025).

DIN 02303502
Primary Designation Designated Partner
First Appointment 15 Nov 2011
Oldest Company Age 33 yrs
Largest company Vedantaa Institutes Of Academic Excellence Private Limited · ₹183 Cr (FY 2025)
Combined revenue ₹183 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director30 May 20142011₹183 Cr (FY 2025)Active
Director01 Oct 20131993₹6,546 (FY 2025)Active
Olive Pharmascience Limited U21002MH2025PLC442746
Director11 Mar 20252025–Active
Designated Partner14 Feb 20252023–Active
Designated Partner15 Jun 20212021–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Jan 20142014₹25.70 Cr (FY 2023)Active
Olive Therapeutics Private Limited U36100MH1993PTC071372
Additional Director01 Apr 20211993–Converted To Llp
Olive Spaces Llp AAA-6878
Partner15 Nov 20112011–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Olive Therapeutics Llp
Vedantaa Institutes Of Academic Excellence Private Limited
Curlew Finlease And Investments Pvt Ltd
Olive Spaces Llp
Premium access

Shareholding and investment profile for Hardik Kamlesh Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardik Kamlesh Shah

Hardik Kamlesh Shah has 14 years in corporate governance. Holds Designated Partner and Whole-Time Director roles. Currently with 5 companies, including Olive Therapeutics Llp and Vedantaa Institutes Of Academic Excellence Private Limited. Formerly with 3 companies, such as Pharmanova Specialties Private Limited and Olive Therapeutics Private Limited. Engaged in General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹183 Cr; the largest is Vedantaa Institutes Of Academic Excellence Private Limited at ₹183 Cr (FY 2025).

Hardik Kamlesh Shah is associated with 5 companies as Designated Partner and Whole-Time Director, including Vedantaa Institutes Of Academic Excellence Private Limited (₹183 Cr), Curlew Finlease And Investments Pvt Ltd (₹6,546), Olive Pharmascience Limited.

Hardik Kamlesh Shah has expertise in General Business.

Hardik Kamlesh Shah has 14 years in corporate governance.

By reported revenue, the largest current company of Hardik Kamlesh Shah is Vedantaa Institutes Of Academic Excellence Private Limited, with revenue of ₹183 Cr (FY 2025).

The 2 current companies of Hardik Kamlesh Shah that report revenue have a combined latest revenue of ₹183 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available